• Home
  • About
  • Africa
  • Americas
  • Asia
  • Europe
  • Middle East
  • Russia
  • South Asia
  • Space
  • World
  • Newsletters
  • Podcast
  • Contributors
  • Write For Us
  • Contact Us
Facebook Twitter YouTube
  • Leaders
  • States
  • Networks
  • Ideologies
  • Technologies
Facebook Twitter YouTube
Globely NewsGlobely News
  • Africa
  • Americas
  • Asia
  • Europe
  • Middle East
  • Russia
  • South Asia
  • Space
  • World
Subscribe
Trending
  • Pro-Russia Bloc Victory in Slovakia Polls Would Mark End of Ukraine Aid
  • Ukraine and Russia Spar Over Invasion’s Legality
  • Ukraine Military Faces Manpower Shortage in War With Russia
  • Imran Khan Remains Pakistan’s Most Popular Politician By Far
  • Vivek Ramaswamy’s Immigration Views Clash With His Real Life Story
  • How the African Union Can the Most of Its G20 Membership
  • Unpacking China’s Moves to Regulate Generative AI
  • Canadian Sikh Killing Should Be the West’s Wakeup Call on India
Globely NewsGlobely News
Home » Deep Learning AI Discovers Surprising New Antibiotics
World

Deep Learning AI Discovers Surprising New Antibiotics

Sriram ChandrasekaranBy Sriram ChandrasekaranFebruary 24, 2020
Facebook Twitter LinkedIn Email Reddit WhatsApp
AI pic
Share
Facebook Twitter LinkedIn Email Reddit WhatsApp

Imagine you’re a fossil hunter. You spend months in the heat of Arizona digging up bones only to find that what you’ve uncovered is from a previously discovered dinosaur.

That’s how the search for antibiotics has panned out recently. The relatively few antibiotic hunters out there keep finding the same types of antibiotics.

With the rapid rise in drug resistance in many pathogens, new antibiotics are desperately needed. It may be only a matter of time before a wound or scratch becomes life-threatening. Yet few new antibiotics have entered the market of late, and even these are just minor variants of old antibiotics.

While the prospects look bleak, the recent revolution in artificial intelligence (AI) offers new hope. In a study published on Feb. 20 in the journal Cell, scientists from MIT and Harvard used a type of AI called deep learning to discover new antibiotics.

The traditional way of discovering antibiotics – from soil or plant extracts – has not revealed new candidates, and there are many social and economic hurdles to solving this problem, as well. Some scientists have recently tried to tackle it by searching the DNA of bacteria for new antibiotic-producing genes. Others are looking for antibiotics in exotic locations such as in our noses.

Drugs found through such unconventional methods face a rocky road to reach the market. The drugs that are effective in a petri dish may not work well inside the body. They may not be absorbed well or may have side effects. Manufacturing these drugs in large quantities is also a significant challenge.

Deep Learning

Enter deep learning. These algorithms power many of today’s facial recognition systems and self-driving cars. They mimic how neurons in our brains operate by learning patterns in data. An individual artificial neuron-like a mini sensor – might detect simple patterns like lines or circles. By using thousands of these artificial neurons, deep learning AI can perform extremely complex tasks like recognizing cats in videos or detecting tumors in biopsy images.

Given its power and success, it might not be surprising to learn that researchers hunting for new drugs are embracing deep learning AI. Yet building an AI method for discovering new drugs is no trivial task. In large part, this is because in the field of AI there’s no free lunch.

The No Free Lunch theorem states that there is no universally superior algorithm. This means that if an algorithm performs spectacularly in one task, say facial recognition, then it will fail spectacularly in a different task, like drug discovery. Hence researchers can’t simply use off-the-shelf deep learning AI.

The Harvard-MIT team used a new type of deep learning AI called graph neural networks for drug discovery. Back in the AI stone age of 2010, AI models for drug discovery were built using text descriptions of chemicals. This is like describing a person’s face through words such as “dark eyes” and “long nose.” These text descriptors are useful but obviously don’t paint the entire picture. The AI method used by the Harvard-MIT team describes chemicals as a network of atoms, which gives the algorithm a more complete picture of the chemical than text descriptions can provide.

Human Knowledge and AI Blank Slates

Yet deep learning alone is not sufficient to discover new antibiotics. It needs to be coupled with deep biological knowledge of infections.

The Harvard-MIT team meticulously trained the AI algorithm with examples of drugs that are effective and those that aren’t. In addition, they used drugs that are known to be safe in humans to train the AI. They then used the AI algorithm to identify potentially safe yet potent antibiotics from millions of chemicals.

Unlike people, AI has no preconceived notions, especially about what an antibiotic should look like. Using old-school AI, my lab recently discovered some surprising candidates for treating tuberculosis, including an anti-psychotic drug. In the study by the Harvard-MIT team, they found a gold mine of new candidates. These candidate drugs do not look anything like existing antibiotics. One promising candidate is Halicin, a drug being explored for treating diabetes.

Halicin, surprisingly, was potent not only against E. coli, the bacteria the AI algorithm was trained on, but also on more deadly pathogens, including those that cause tuberculosis and colon inflammation. Notably, Halicin was potent against drug-resistant Acinetobacter baumanni. This bacterium tops the list of most deadly pathogens compiled by the Centers for Disease Control and Prevention.

Unfortunately, Halicin’s broad potency suggests that it may also destroy harmless bacteria in our body. It may also have metabolic side effects since it was originally designed as an anti-diabetic drug. Given the dire need for new antibiotics, these may be small sacrifices to pay to save lives.

Keeping Ahead of Evolution

Given the promise of Halicin, should we stop the search for new antibiotics?

Halicin might clear all hurdles and eventually reach the market. But it still needs to overcome an unrelenting foe that’s the main cause of the drug resistance crisis: evolution. Humans have thrown numerous drugs at pathogens over the past century. Yet pathogens have always evolved resistance. So it likely wouldn’t be long until we encounter a Halicin-resistant infection. Nevertheless, with the power of deep learning AI, we may now be better suited to quickly respond with a new antibiotic.

Many challenges lie ahead for potential antibiotics discovered using AI to reach the clinic. The conditions in which these drugs are tested are different from those inside the human body. New AI tools are being built by my lab and others to simulate the body’s internal environment to assess antibiotic potency. AI models can also now predict drug toxicity and side effects. These AI technologies together may soon give us a leg up in the never-ending battle against drug resistance.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Sriram Chandrasekaran

Sriram Chandrasekaran is an assistant professor of biomedical engineering at the University of Michigan.

    This author does not have any more posts.
Artificial Intelligence Featured Public Health

More from Globely News

Unpacking China’s Moves to Regulate Generative AI

September 27, 2023

AI Can Lead to Even More Deceptive Political Campaigning

July 28, 2023

Here’s Where Gas is the Most Expensive in the U.S.

June 27, 2023

Vladimir Putin’s Approval Rating Remains Sky High. Here’s Why.

June 23, 2023

As Modi Meets Biden, India Skepticism Grows. But Does It Matter?

June 22, 2023

As U.S. Rivalry With China and Russia Grows, Global South Goes Its Own Way

June 19, 2023
Add A Comment

Comments are closed.

Newsletter

Subscribe to the Globely Daily

Our flagship newsletter covers the leaders, states, networks, ideologies, and technologies that are transforming world power.

Pro-Russia Bloc Victory in Slovakia Polls Would Mark End of Ukraine Aid

September 29, 2023

Ukraine and Russia Spar Over Invasion’s Legality

September 29, 2023

Ukraine Military Faces Manpower Shortage in War With Russia

September 28, 2023

Imran Khan Remains Pakistan’s Most Popular Politician By Far

September 28, 2023
© 2023 Globely News.
  • Home
  • About
  • Editorial Policy
  • Privacy Policy
  • Terms of Use
  • Contributors
  • Write For Us
  • Contact Us

Type above and press Enter to search. Press Esc to cancel.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT

Ad Blocker Enabled

Ad Blocker Enabled
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.
Go to mobile version